Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCN3028 for Drug-Induced Hot Flashes in Breast Cancer
NCT06161792Phase 2Terminated
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Nov 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risperidone in hot flashes, sponsored by Yung Shin Pharmaceutical Industry. Started Nov 2019; status: terminated.
02
Drugs
risperidone
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT06161792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06161792.